Repligen (RGEN) Research & Development (2016 - 2025)
Repligen (RGEN) has disclosed Research & Development for 16 consecutive years, with $13.1 million as the latest value for Q4 2025.
- Quarterly Research & Development rose 12.36% to $13.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $54.2 million through Dec 2025, up 25.41% year-over-year, with the annual reading at $54.2 million for FY2025, 25.41% up from the prior year.
- Research & Development for Q4 2025 was $13.1 million at Repligen, down from $14.2 million in the prior quarter.
- The five-year high for Research & Development was $14.2 million in Q3 2025, with the low at $7.6 million in Q1 2021.
- Average Research & Development over 5 years is $10.9 million, with a median of $10.6 million recorded in 2023.
- The sharpest move saw Research & Development soared 107.01% in 2021, then dropped 8.2% in 2024.
- Over 5 years, Research & Development stood at $9.1 million in 2021, then rose by 21.87% to $11.1 million in 2022, then fell by 7.45% to $10.3 million in 2023, then rose by 13.53% to $11.7 million in 2024, then grew by 12.36% to $13.1 million in 2025.
- According to Business Quant data, Research & Development over the past three periods came in at $13.1 million, $14.2 million, and $14.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.